Genvax Technologies Competitors and Similar CompaniesClear all
Genvax Technologies's competitors and similar companies include Novoprotein, Anke Biological Engineering, OliPass Corporation and Sonoma BioTherapeutics.
 Genvax Technologies Genvax Technologies is a company that develops mRNA and nanoparticle vaccines for animal health. |  Novoprotein Novoprotein (also known as 诺唯赞) is a biotechnology company that develops and supplies recombinant proteins, reagents, and contract research and manufacturing services for biopharmaceutical and research purposes. |  Anke Biological Engineering Anke Biological Engineering is engaged in the research, development, and production of genetic engineering drugs. |  OliPass Corporation OliPass Corporation (previously known as CTI-Bio) is a biotech company focused on healthy aging. |  Sonoma BioTherapeutics Sonoma BioTherapeutics is a company that develops a regulatory T-cell therapy for autoimmune and degenerative diseases. | |
Founding Date | Founding Date 2021 | Founding Date 2009 | Founding Date 1993 | Founding Date 2006 | Founding Date 2019 |
Type | Type Private | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Ames, US HQ | Locations Hefei Shi, CN HQ | Locations Yongin-si, KR HQ Suwon, KR | Locations South San Francisco, US HQ Seattle, US | |
Employees | Employees 8 | Employees 566 | Employees N/A | Employees 78 | Employees 1153% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥144.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩756m (FY, 2024) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods ¥48.1m (FY, 2025) | Cost of goods N/A | Cost of goods (₩288.8m) (FY, 2024) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit ¥96.8m (FY, 2025) | Gross profit N/A | Gross profit ₩6.2b (FY, 2024) | Gross profit N/A |
Net income | Net income N/A | Net income (¥77.8m) (FY, 2025) | Net income N/A | Net income (₩5.3b) (FY, 2024) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 18.4m | Total funding raised $ 70m |
For sources of this data, please see the company profile
View Company Profiles
Novoprotein
HQ
Suzhou, CN
Employees
566
Novoprotein (also known as 诺唯赞) is a biotechnology company that develops and supplies recombinant proteins, reagents, and contract research and manufacturing services for biopharmaceutical and research purposes.
View companyAnke Biological Engineering
HQ
Hefei Shi, CN
Anke Biological Engineering is engaged in the research, development, and production of genetic engineering drugs.
View companyOliPass Corporation
HQ
Yongin-si, KR
Employees
78
OliPass Corporation (previously known as CTI-Bio) is a biotech company focused on healthy aging.
View companySonoma BioTherapeutics
HQ
South San Francisco, US
Employees
115↓ 3% decrease
Sonoma BioTherapeutics is a company that develops a regulatory T-cell therapy for autoimmune and degenerative diseases.
View company